Drug Profile
Research programme: heat shock protein 90 inhibitors - TopoTarget
Alternative Names: HSP90 inhibitors - TopoTargetLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator TopoTarget
- Class Small molecules
- Mechanism of Action HSP90 heat-shock protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 04 Sep 2008 Preclinical development is ongoing in Denmark